MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This study will compare the efficacy and safety of different treatment regimens of oral
Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily
supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+
years, and the target sample size is 500+ individuals.
Phase:
Phase 3
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Calcium Calcium, Dietary Diphosphonates Ergocalciferols Ibandronic Acid Vitamin D Vitamins